Advisory Board

Professor Evelyne Yehudit Bischof

Evelyne Yehudit Bischof, MD, MPH, FEFIM, FMH is Associate Professor at the Shanghai University of Medicine & Health Sciences, Chief Associate Physician of Internal Medicine and Oncology at the University Hospital Renji of Shanghai Jiao Tong University School of Medicine, and Emergency Medicine Physician at the Shanghai East International Medical Center.

She is a specialist and expert in Internal Medicine with a research focus on Artificial Intelligence and Digital Health, especially in the fields of Oncology, Preventative and Precision Medicine, Biogerontology, and Geronto-Oncology.

Evelyne is Longevity Physician at Human Longevity since 2020. Built by the pioneers of the human genome sequencing effort, Human Longevity is the global leader in advancing the Human Longevity Care movement, on a mission to discover and harness the technological and biological advances that amplify the span of life, health, and high-performance.

She is also Executive Concierge and Longevity Physician at EPO8 (Executive Performance Optimization 8), leading elite executives as longevity patients, integrating precision diagnostics of HLI, AI-based monitoring with deep aging analysis, and individualized therapies towards healthy longevity, reversing the biological age, and achieving optimal performance.

Evelyne is passionate about next-generation medical technology and the applications of artificial intelligence for biomedical research and practice.

At the Longevity Medicine Course (LMC), Evelyne helps and works with groups of scientists, medical doctors, and research physicians brought together by Alex Zhavoronkov to provide medical professionals with the most recent advances in biogerontology, geroscience, and precision medicine while teaching them ways to implement this knowledge in clinical practice.

She is Scientific Advisor at LongeVC, Holmusk, and Maximon, Clinical Advisor at Insilico Medicine since 2019, and Head of the Visionary Board at the Longevity Science Foundation.

Read $1B longevity fund launches to pursue 120+ lifespan.

One of the main focuses of the Longevity Science Foundation is to drive longevity medicine from theoretical concepts to real-world applications. They support the transformation of scientific findings and deep technological advances into treatments and solutions that can be used in the clinic today.

Holmusk is building the largest Real-World Evidence platform, starting with behavioral health. Combining a leading behavioral health database with AI-powered analytics and digital solutions, they are advancing the evidence of generation and innovation.

At Insilico Medicine, an artificial intelligence-driven pharma technology company, they are accelerating drug discovery and development by leveraging their proprietary platform across biology, chemistry, and clinical development. Their Pharma.AI platform has the potential to rapidly bring novel breakthrough medicines to patients while decreasing costs and increasing the probabilities of success.

Evelyne has published more than 80 peer-reviewed papers and is a frequent speaker at scientific and medical conferences in Asia and in Europe. Among others, she was an Invited Speaker at Metabesity 2021, The Longevity Summit, OncoXchange, and ARDD.

She is a Swiss board certified (FMH) trained in Harvard Medical School affiliated hospitals (Massachusetts General Hospital, Beth Israel Medical Center, Dana Farber Institute), Columbia University NYC, Tongji University hospitals, Shanghai, and University Hospitals of Zurich and Basel in Switzerland.

Evelyne earned her MD from Tongji University in 2014 where she Lectured between 2011 and 2016. She was Doctoral Student at the Max Planck Institute for two years until 2008 and was MEP Assistant at European Parliament until 2009 in Belgium.

In 2010, Evelyne continued with her Medical training and became Medical Intern at Columbia University in 2010 and at Harvard Medical School in 2011.

For a year, in 2012, Evelyne was Resident Physician at the University Hospital Zürich, before she left for Shanghai for her MD.

After that, she became an Attending Physician at the University Hospital Basel until 2018 and an Associate Professor at the Shanghai University of Medicine & Health Sciences, where she continues today.

Evelyne spent a decade practicing medicine, lecturing, and performing clinical and translational research in New York, Shanghai, and Basel, with extensive experience in scientific research and clinical practice at the University Hospital of Basel, Fudan Cancer Institute and Hospital, Zhongshan Hospital, Renji Hospital, and Shanghai East Hospital.

She has been a Long term Member of various medical societies, including the European Federation of Internal Medicine, World Academy of Medical Sciences, and the Swiss Society of Internal Medicine.

Watch AI Series: Precision medicine in practice — diagnostic algorithms & gerontology.

Read Women In Longevity Medicine And The Rise Of The Longevity Physician and Scientists publish a blueprint to apply artificial intelligence to extend human longevity.

Watch BrainKey Talks — Episode 3 with Evelyne, Advancing The Frontiers Of Preventative And Precision Longevity Medicine, and Meet Evelyne Bischof, MD Calling it in From Shanghai This Week on Talk Fast Listen Slow.

Visit her LinkedIn profile and her ResearchGate page. Follow her on Facebook, Instagram, and Twitter.